½ÃÀ庸°í¼­
»óǰÄÚµå
1297773

¼¼°èÀÇ µðÁöÅÐ Çコ ½ÃÀå(2023-2030³â)

Global Digital Health Market - 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

½ÃÀå °³¿ä

¼¼°è µðÁöÅÐ Çコ ½ÃÀåÀº 2022³â 2,232¾ï ´Þ·¯, 2030³â¿¡´Â 8,503¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼¼°è µðÁöÅÐ Çコ ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 18.9%ÀÇ CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â¼ú ¹ßÀü°ú ½ÅÁ¦Ç° ÀÓ»ó ½ÃÇèÀÇ Áõ°¡´Â µðÁöÅÐ Çコ ½ÃÀå µ¿Çâ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

Çõ½ÅÀûÀÎ ±â¼ú °³¹ß, ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º ¹ßÀü, »õ·Î¿î ¾÷µ¥ÀÌÆ® Ãâ½Ã, ȯÀÚ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ È¯ÀÚ Áõ°¡ µîÀÌ ¼¼°è µðÁöÅÐ Çコ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

µðÁöÅÐ Çコ ½ÃÀåÀÇ ¹üÀ§´Â ±¸¼º¿ä¼Ò, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚ·Î ±¸¼ºµÇ¾î µðÁöÅÐ Çコ ½ÃÀå Á¡À¯À²À» È®´ëÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ °Ç°­ ¼¼°è ½ÃÀåÀº ¿¬±¸°³¹ßÀÇ Áõ°¡¿Í °¢±¹ÀÇ ½ÅÁ¦Ç° ½ÂÀÎ µîÀÇ ¿äÀÎÀ¸·Î È®´ëµÇ°í ÀÖÀ¸¸ç, µðÁöÅÐ °Ç°­ ½ÃÀåÀÇ ¼ºÀå Àü¸Áµµ ¹à¾ÆÁö°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¿¬±¸°³¹ß ¹× ½ÅÁ¦Ç° Ãâ½Ã Áõ°¡·Î µðÁöÅÐ Çコ ½ÃÀå ¼ºÀå °ßÀÎ

¾ÆÁ÷ ÃæºÐÇÑ µ¥ÀÌÅͰ¡ ºÎÁ·ÇÏÁö¸¸, ÀÇ·á°è´Â ¿þ¾î·¯ºí ±â¼úÀ» ȯÀÚ Áø·á¿¡ Á¡Â÷ÀûÀ¸·Î µµÀÔÇϱ⠽ÃÀÛÇß½À´Ï´Ù. ¹Ì±¹ ÀÇ·á±â±â-¹æ»ç¼±º¸°Ç¼¾ÅÍ(CDRH)ÀÇ µðÁöÅÐÇコ¼¾ÅÍ(DHCoE)´Â Ã¥ÀÓ°¨ ÀÖ´Â µðÁöÅÐÇコ Çõ½ÅÀ» Áö¿øÇÏ°í °úÇÐ ¿¬±¸¿Í ÆÄÆ®³Ê½ÊÀ» ÅëÇØ °øÁߺ¸°ÇÀ» º¸È£Çϰí ÁõÁøÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

CDRH´Â µðÁöÅÐ Çコ Áß½ÉÀÇ Çù¾÷À» ÅëÇØ FDAÀÇ Àü¹®°¡µéÀÌ »õ·Î¿î µðÁöÅÐ Çコ ±â¼ú°ú °ü·ÃµÈ ÀÌÁ¡°ú À§ÇèÀ» ÀÌÇØÇÏ°í Æò°¡ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â ±ÔÁ¦ °úÇÐ ¿¬±¸¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù. °úÇÐÀûÀÌ°í Æí°ß ¾ø´Â °´°üÀûÀÎ Àü¹®Áö½ÄÀ» Á¦°øÇÔÀ¸·Î½á ÀÌ Á¶»ç´Â ȯÀÚ¿Í ¼ÒºñÀÚ°¡ »ç¿ëÇÏ´Â Á¦Ç°¿¡ ´ëÇÑ ¾ÈÀü¼ºÀ» º¸ÀåÇϰí À§Çظ¦ ÁÙÀÌ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù.

Á¤ºÎ Áö¿ø°ú ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡´Â Á¦Á¶¾÷ü¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâ

Á¤ºÎÀÇ Áö¿ø°ú ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡´Â µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, À¯·´À§¿øÈ¸¿Í ¼¼°èº¸°Ç±â±¸(WHO)´Â µðÁöÅÐ °Ç°­ ºÐ¾ß¿¡¼­ ¿ª»çÀûÀÎ Á¦ÈÞ¸¦ ½ÃÀÛÇß½À´Ï´Ù.

À¯·´¿¬ÇÕ(EU) µðÁöÅÐ COVID-19 ÀÎÁõ Ç÷§ÆûÀº 2023³â 6¿ù WHO¿¡ äÅÃµÇ¾î ±¹°æ °£ À̵¿À» ¿ëÀÌÇÏ°Ô Çϰí Àü¿°º´°ú °°Àº ÇöÀç ¹× ÀáÀçÀû °Ç°­ À§ÇèÀ¸·ÎºÎÅÍ Àü ¼¼°è »ç¶÷µéÀ» º¸È£ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ¼¼°è ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¿¹Á¤ÀÔ´Ï´Ù. µðÁöÅÐ °Ç°­ ÀÎÁõ ³×Æ®¿öÅ©(GDHCN)´Â ¸ðµç »ç¶÷µéÀÇ °Ç°­ ÁõÁøÀ» ÃËÁøÇϱâ À§ÇØ ´Ù¾çÇÑ µðÁöÅÐ Á¦Ç°À» ¸¸µé °ÍÀ̸ç, À̸¦ ù ¹øÂ° ÁÖÃåµ¹·Î »ï°í ÀÖ½À´Ï´Ù.

ÀÌ ÇÁ·ÎÁ§Æ®´Â 2022³â 11¿ù 30ÀÏ Å×µå·Î½º ¹Ú»ç¿Í ۸®¾ÆÅ°µ¥½º À§¿øÀåÀÌ Ã¼°áÇÑ ¼¼°èº¸°Ç¿¡ ´ëÇÑ Àü·«Àû Çù·Â °ü°è¸¦ °­È­Çϱâ À§ÇÑ ÇÕÀÇ¿¡ µû¸¥ °ÍÀÔ´Ï´Ù. ÀÌ ÇÁ·ÎÁ§Æ®´Â WHO¿Í EUÀÇ µðÁöÅÐ º¸°Ç¿¡ °üÇÑ ¼¼°è º¸°Ç Àü·«¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ Çコ °ü·Ã ´ÜÁ¡Àº ½ÃÀå ¼ºÀåÀ» ÀúÇØ

¾Û ÄÁÅÙÃ÷´Â ´Ù¸¥ µðÁöÅÐ Á¤º¸¿Í ¸¶Âù°¡Áö·Î µ¥ÀÌÅÍ À¯Ãâ°ú ÇØÄ¿ÀÇ °ø°Ý¿¡ Ãë¾àÇÕ´Ï´Ù. ¶ÇÇÑ, ¾ÛÀº »çÀûÀÌ°í °³ÀÎÀûÀÎ »ç¿ëÀÚ µ¥ÀÌÅ͸¦ À¯ÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ð¹ÙÀÏ ¾ÛÀÇ ÄÁÅÙÃ÷´Â ÀÇÇÐ Àú³Î¿¡ °ÔÀçµÇ´Â ÄÁÅÙÃ÷º¸´Ù °¨½ÃÀÇ ´«À» ÇÇÇÏ±â ¾î·Æ½À´Ï´Ù. ¿¹¸¦ µé¾î, Ç÷¾ÐÀ» ÃøÁ¤ÇÒ ¶§ À߸øµÈ °á°ú°¡ ³ª¿Ã ¼ö ÀÖ½À´Ï´Ù.

ÇÑÆí, ±â¼ú ÀÚü¿¡µµ ¹®Á¦°¡ ÀÖ½À´Ï´Ù. ¹«¼± ¿¬°á, ¼ÒÇÁÆ®¿þ¾î, Çϵå¿þ¾î´Â ¿À·ù°¡ ¾ø´Â °ÍÀÌ ¾Æ´Õ´Ï´Ù. °©Àڱ⠸ØÃç ¹ö¸®°Å³ª °¡»ó °Ë»ç Áß¿¡ ¸ØÃç ¹ö¸®´Â °æ¿ìµµ ÀÖ½À´Ï´Ù. ¾î¶² »ç¶÷µé¿¡°Ô´Â ±â¼ú·ÎÀÇ ÀüȯÀÌ ´õ Å« µµÀüÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ÀÇ·á Ȱµ¿°ú °ü·ÃÇÏ¿© °¢ ÁÖ¸¶´Ù °íÀ¯ÇÑ ¹ý·ü°ú °¡À̵å¶óÀÎÀÌ ÀÖ½À´Ï´Ù. ´Ù½Ã ¸»ÇÏÁö¸¸, ±â¼ú¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÇØÄ¿¿Í º¸¾È Ä§ÇØ·ÎºÎÅÍ ¼¼ºÎ »çÇ×ÀÌ ¾ó¸¶³ª ¾ÈÀüÇÏ°Ô º¸È£µÇ°í ÀÖ´ÂÁö¿¡ ´ëÇÑ ¿ì·Á°¡ Ä¿Áö°í ÀÖ½À´Ï´Ù.

COVID-19 ¿µÇ⠺м®

COVID-19ÀÇ È®»ê°ú Àü ¼¼°è ºÀ¼â·Î ÀÎÇØ ¸ðµç »ê¾÷ ºÐ¾ßÀÇ ±â¾÷ À繫 »óȲ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº COVID-19 º¸°Ç ºñ»ó»çÅ¿¡ ´ëÇÑ °¡À̵å¶óÀÎÀ» ¹ßÇ¥ÇÏ¿© ÀÓ»ó½ÃÇè ÀÇ·ÚÀÚ¿Í ¿¬±¸ÀÚ¸¦ Áö¿øÇϰí, ÀÓ»ó½ÃÇè Âü°¡ÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇϸç, ÀÓ»ó½ÃÇèÀÇ ¹«°á¼º¿¡ ´ëÇÑ À§ÇèÀ» ÁÙÀ̱â À§ÇÑ ÀϹÝÀû °í·Á»çÇ×À» Æ÷ÇÔÇß½À´Ï´Ù. ¸¦ Æ÷ÇÔÇÕ´Ï´Ù.

·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ºÐÀïÀÇ ¿µÇ⠺м®

·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ºÐÀïÀº ÀÌ Áö¿ªÀÇ ÁÖ¿ä ½ÃÀå Âü¿©ÀÚ ¼ö°¡ Àû±â ¶§¹®¿¡ ¼¼°è µðÁöÅÐ Çコ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº ¹Ì¹ÌÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ±×·¯³ª ¿øÀÚÀç ¼öÀÔ ¹× ¼öÃâÀÇ ¿µÇâÀº ¿¹Ãø ±â°£ µ¿¾È ¼¼°è µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼ºÀå¿¡ °ÅÀÇ ¿µÇâÀ» ¹ÌÄ¡Áö ¾ÊÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¿ø°Ý °¨½Ã ¼­ºñ½º ¼ö¿ä Áõ°¡
      • Á¤ºÎ Áö¿ø°ú ´ëó °­È­
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
      • µðÁöÅÐ Çコ¿¡ µû¸¥ ´ÜÁ¡
    • ±âȸ
      • ¿¬±¸°³¹ß Áõ°¡¿Í ½ÅÁ¦Ç° ¹ß¸Å
    • ¿µÇ⠺м®

Á¦5Àå ¾÷°è ºÐ¼®

  • Porter's Five Forces ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±ÔÁ¦ ºÐ¼®

Á¦6Àå COVID-19 ºÐ¼®

Á¦7Àå ÄÄÆ÷³ÍÆ®º°

  • Çϵå¿þ¾î
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦8Àå ±â¼úº°

  • ¸ð¹ÙÀÏ Çコ(mHealth)
    • ¿þ¾î·¯ºí
      • Ç÷´çÃøÁ¤±â
      • »ê¼ÒÆ÷È­µµÃøÁ¤±â
      • ½ÉÀå ¸ð´ÏÅÍ
      • ¹«È£Èí ¹× ¼ö¸é ¸ð´ÏÅÍ
      • ½Å°æ ¸ð´ÏÅÍ
      • ±âŸ
    • ¾Û
      • ÇÇÆ®´Ï½º ¾Û
      • ÀÇ·á ¾Û
  • e-Health
    • ÀüÀڰǰ­±â·Ï(EHR)
    • º¥´õ Á߸³ ¾ÆÄ«À̺ê(VNA) ¹× ¿µ»ó ¾ÆÄ«ÀÌºê ¹× Ä¿¹Â´ÏÄÉÀÌ¼Ç ½Ã½ºÅÛ(PACS)
    • ¿¬±¸½Ç Á¤º¸ ½Ã½ºÅÛ(LIS)
    • ó¹æ ¼Ö·ç¼Ç
  • ¿ø°ÝÀÇ·á
    • ¿ø°ÝÀÇ·á
      • ºñµð¿À »ó´ã
      • LTC ¸ð´ÏÅ͸µ
    • ÅÚ·¹Äɾî
      • ¿ø°Ý Åõ¾à °ü¸®
      • Ȱµ¿ ¸ð´ÏÅ͸µ
  • °Ç°­ ºÐ¼®

Á¦9Àå ÃÖÁ¾»ç¿ëÀÚº°

  • ÇコÄɾî Á¦°øÀÚ
  • ÇコÄÉ¾î ¼ÒºñÀÚ
  • ±âŸ

Á¦10Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ÁÖ¿ä Áö¿ª °íÀ¯ÀÇ ¿ªÇÐ

Á¦11Àå °æÀï »óȲ

  • °æÀï ½Ã³ª¸®¿À
  • ½ÃÀå Æ÷Áö¼Å´×/Á¡À¯À² ºÐ¼®
  • ÀμöÇÕº´ ºÐ¼®

Á¦12Àå ±â¾÷ °³¿ä

  • BioTelemetry, a Philips Company
    • ±â¾÷ °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼³¸í
    • À繫 °³¿ä
    • ÁÖ¿ä ¹ßÀü
  • Veradigm LLC
  • EClinicalWorks
  • IHealth Labs Inc
  • Athenahealth Inc.
  • AT&T
  • Honeywell International Inc.
  • Cisco Systems, Inc.
  • AdvancedMD, Inc.
  • McKesson Corporation

Á¦13Àå ºÎ·Ï

ksm 23.07.11

Market Overview

The Global Digital Health Market reached US$ 223.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 850.3 billion by 2030. The Global Digital Health Market is expected to exhibit a CAGR of 18.9% during the forecast period 2023-2030. The increasing technological advancements and clinical trials for novel products drive demand for digital health market trends.

The development of innovative technologies, advancements in software and services, the launch of new updates, and an increase in a number of patients requiring patient monitoring are the main factors propelling the global market for digital health.

The Digital Health Market scope comprises components, technology and end-user, increasing the digital health market share. The global market for digital health is expanding due to factors including increasing research and development and their upcoming novel product approvals across countries are also creating a positive outlook for the digital health market growth.

Market Dynamics

Rising Research and Development and Novel Product Launches Drive the Growth of the Digital Health market.

Even though there isn't yet enough data to support its widespread use, healthcare is slowly beginning to integrate wearable technology in patient care. The Center for Devices and Radiological Health's (CDRH) Digital Health Center of Excellence (DHCoE) aims to support responsible digital health innovation and protect and promote public health, including scientific research and partnerships.

Through collaborations centered on digital health, CDRH is promoting regulatory science research, which allows FDA experts to comprehend and evaluate the advantages and risks associated with emerging digital health technologies. By offering scientific, unbiased, and objective expertise, this research helps guarantee the safety or lessen the harm related to goods used by patients and consumers.

Increased Government Support and Initiatives creates Lucrative Opportunities for Manufacturers

There are rising government support and initiatives are the major factors driving the growth of the digital health market. For instance, the European Commission and the World Health Organization (WHO) launched a historic alliance in digital health.

The European Union (EU) platform for digital COVID-19 certification will be adopted by WHO in June 2023 to create a global system that will aid in facilitating cross-border mobility and safeguarding people all over the world from present and potential health dangers, such as pandemics. The WHO Global Digital Health Certification Network (GDHCN), which will create various digital products to promote improved health for all, has this as its first cornerstone.

The project follows the 30 November 2022 deal between Dr. Tedros and Commissioner Kyriakides to increase strategic collaboration on global health concerns. It depends on the WHO and EU Global Health Strategy on Digital Health.

Disadvantages Associated with Digital Health will Hamper the Growth of the Market.

App content is vulnerable to data breaches and hackers like other digital information. Additionally, an app can divulge user data that is private and personal. Additionally, the content in mobile apps is less monitored than that found in medical journals. For instance, they might produce erroneous findings when measuring blood pressure.

On the other hand, technology itself presents difficulties. Wireless connections, software, and hardware are not error-free. They may stop working suddenly or in during the course of a virtual test. For certain individuals, converting to technology can potentially provide a greater challenge.

Regarding telemedicine and telehealth activities, each state has its own laws and guidelines. Again, there are growing worries about how secure and safeguarded details are from hackers and security breaches as we depend more heavily on technology.

COVID-19 Impact Analysis

The COVID-19 epidemic and the worldwide lockdown have affected the financial health of businesses in all industries. As a result, the U.S. Food and Drug Administration (FDA) released guidelines for the COVID-19 health emergency, including general considerations to assist sponsors and researchers, ensure trial participants' safety, follow good clinical practice (GCP), and reduce risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global digital health market, owing to the low number of key market players in this region. However, the effect of the import and export of raw materials is expected to have little influence over the Global Digital Health market growth over the forecast period.

Segment Analysis

The Global Digital Health Market is segmented based on component, technology, end user and region.

mHealth from Technology Accounts for 27.2% of Market Share Owing to Rising Utilization

Over the past year, the field of digital health has experienced tremendous growth. Electronic health, mobile health, and telehealth are all used to refer to the use of desktop and mobile technology for patient management. The phrase "mHealth," or "mobile health," implies the application of portable technologies, such as tablets and smartphones, to support medical processes.

Patients can log, save, and analyze their health data on their own mobile devices using mHealth services. These programs aid in increasing the effectiveness of the dissemination of medical information. Apps for mobile health may be useful for researchers, patients, and healthcare professionals.

Additionally, mobile health-tracking apps are becoming more widely used daily. There are more than 318,000 health applications available for download. GoogleFit, Fitbit, and Apple Heart Study are a few well-known mHealth app examples.

Geographical Analysis

North America Accounted for Approximately 45.3% of the Market Share Owing to the Strong Presence of Major Players and Rising Technological Advancements

Manufacturers have chances to expand their operations in this region because of the rising demand for digital health for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of digital health, increasing demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for novel technologies.

The market will grow as new components or technology for healthcare emerge. Rising technological developments, governmental approvals, and introducing new products all contribute to growth. People are becoming more aware of novel technologies and apps for digital healthcare, leading to the market expansion in this region. These factors show the dominance of North America.

Competitive Landscape

The major global players in the digital health market include: BioTelemetry, a Philips Company, EClinicalWorks, Veradigm LLC, IHealth Labs Inc, AT&T, Athenahealth Inc., Honeywell International Inc., AdvancedMD, Inc., Cisco Systems, Inc. and McKesson Corporation among others.

Why Purchase the Report?

  • To visualize the Global Digital Health Market segmentation based on component, technology, end user and region, and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous digital health market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Digital Health Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Technology
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Remote Monitoring Services Demand
      • 4.1.1.2. Increased Government Support and Initiatives
    • 4.1.2. Restraints
      • 4.1.2.1. Disadvantages Associated with Digital Health
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Research and Development and Novel Product Launches
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Hardware *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Software
  • 7.4. Services

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. mHealth *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Wearables
      • 8.2.3.1. Blood Glucose Meter
      • 8.2.3.2. Pulse Oximetry
      • 8.2.3.3. Cardiac Monitors
      • 8.2.3.4. Apnea & Sleep Monitors
      • 8.2.3.5. Neurological Monitors
      • 8.2.3.6. Others
    • 8.2.4. Apps
      • 8.2.4.1. Fitness Apps
      • 8.2.4.2. Medical Apps
  • 8.3. eHealth
    • 8.3.1. Electronic Health Records (EHR)
    • 8.3.2. Vendor Neutral Archive (VNA) and Picture Archiving & Communications Systems (PACS)
    • 8.3.3. Laboratory Information Systems (LIS)
    • 8.3.4. Prescribing Solutions
  • 8.4. Telehealthcare
    • 8.4.1. Telehealth
      • 8.4.1.1. Video Consultation
      • 8.4.1.2. LTC Monitoring
    • 8.4.2. Telecare
      • 8.4.2.1. Remote Medication Management
      • 8.4.2.2. Activity Monitoring
  • 8.5. Health Analytics

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Healthcare Providers *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Healthcare Consumers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. BioTelemetry, a Philips Company *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Veradigm LLC
  • 12.3. EClinicalWorks
  • 12.4. IHealth Labs Inc
  • 12.5. Athenahealth Inc.
  • 12.6. AT&T
  • 12.7. Honeywell International Inc.
  • 12.8. Cisco Systems, Inc.
  • 12.9. AdvancedMD, Inc.
  • 12.10. McKesson Corporation

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦